AVTX — AVALO THERAPEUTICS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 136 SEC-registered investment managers reported holding AVTX (AVALO THERAPEUTICS INC) in their latest 13F filings, with a combined reported value of $1.32B across 72.93M shares. That is +112.9% by share count (+29.15M shares) versus the previous quarter, while reported value moved +163.6%. Ownership is concentrated: the five largest holders account for 26.9% of reported value and the top ten for 44.5%.
Compared with the prior quarter, 59 opened new positions, 49 added to existing stakes, 20 trimmed, 29 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of AVALO THERAPEUTICS INC (AVTX) include Fidelity Management & Research (FMR), BlackRock Inc, Deep Track Capital, LP, ranked by reported 13F value among the 224 institutional holders on this page.
AVTX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 90 | 28.73M | $438.14M | +13.9% |
| Q2 2026 | 136 | 72.93M | $1.32B | +112.9% |
| Q1 2026 | 106 | 32.75M | $488.69M | +34.0% |
| Q4 2025 | 86 | 20.27M | $368.01M | +19.4% |
| Q3 2025 | 66 | 14.90M | $189.36M | +20.9% |
| Q2 2025 | 35 | 7.84M | $39.11M | -4.2% |
| Q1 2025 | 32 | 8.15M | $65.27M | -11.2% |
| Q4 2024 | 32 | 7.46M | $55.41M | +15.6% |
Over the 8 quarters shown, institutional share counts increased 285% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q2 2026 (+112.9%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 5.25M | $80.49M | 0.00% | Add | |
| 4.96M | $76.03M | 0.00% | Add | |
| 3.24M | $49.74M | 2.32% | Add | |
| 2.56M | $39.29M | 0.00% | Add | |
| 2.26M | $34.59M | 0.00% | Hold | |
| 2.14M | $32.84M | 1.51% | Add | |
| 1.26M | $19.36M | 0.00% | Add | |
| 770.06K | $11.81M | 0.01% | Reduce | |
| 564.44K | $8.65M | 1.68% | Add | |
| 434.03K | $6.65M | 2.71% | Hold | |
| 432.67K | $6.63M | 0.00% | Add | |
| 410.51K | $6.29M | 0.02% | New | |
| 333.32K | $5.11M | 0.00% | Add | |
| 316.50K | $4.85M | 0.00% | New | |
| 275.00K | $4.22M | 0.48% | Hold | |
| 235.09K | $3.60M | 0.65% | Hold | |
| 223.91K | $3.43M | 0.01% | Add | |
| 221.29K | $3.39M | 0.01% | Add | |
| 210.33K | $3.22M | 0.04% | Add | |
| 189.00K | $2.90M | 0.28% | Hold | |
| 177.29K | $2.72M | 2.02% | Add | |
| 176.67K | $2.71M | 0.71% | Add | |
| 153.34K | $2.35M | 0.11% | Add | |
| 139.80K | $2.14M | 0.00% | Add | |
| 289.92K | $2.05M | 0.00% | Reduce |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 2.88M | $42.99M | 0.00% | Add | |
| 2.16M | $32.29M | 0.02% | New | |
| 1.64M | $24.41M | 1.88% | Add | |
| 1.63M | $24.38M | 0.78% | Add | |
| 1.41M | $21.05M | 0.26% | New | |
| 1.34M | $20.02M | 1.08% | Add | |
| 1.24M | $18.44M | 0.84% | Hold | |
| 1.14M | $17.05M | 0.01% | Add | |
| 916.14K | $13.68M | 0.06% | Add | |
| 916.00K | $13.68M | 0.09% | New | |
| 916.00K | $13.68M | 0.08% | New | |
| 856.96K | $12.79M | 0.13% | New | |
| 854.00K | $12.75M | 0.02% | Add | |
| 835.48K | $12.47M | 0.01% | Add | |
| 835.48K | $12.47M | 0.02% | Add | |
| 738.38K | $11.02M | 0.32% | Add | |
| 731.59K | $10.92M | 0.04% | Add | |
| 719.69K | $10.75M | 0.00% | New | |
| 662.97K | $9.90M | 0.10% | Hold | |
| 643.00K | $9.60M | 0.00% | Add | |
| 483.00K | $7.21M | 0.42% | Hold | |
| 475.17K | $7.09M | 0.15% | Reduce | |
| 470.77K | $7.03M | 0.01% | Reduce | |
| 455.00K | $6.79M | 0.13% | Add | |
| 441.98K | $6.60M | 0.27% | Hold |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.36M | $24.61M | 0.83% | Hold | |
| 1.24M | $22.43M | 1.12% | Hold | |
| 1.19M | $21.56M | 0.46% | Reduce | |
| 1.05M | $19.09M | 1.16% | Add | |
| 881.53K | $16.01M | 1.50% | Add | |
| 804.08K | $14.60M | 0.00% | Add | |
| 662.97K | $12.04M | 0.12% | Hold | |
| 659.98K | $11.99M | 0.01% | Add | |
| 659.98K | $11.99M | 0.02% | Add | |
| 627.50K | $11.40M | 0.04% | Reduce | |
| 621.35K | $11.28M | 0.00% | Add | |
| 550.00K | $9.99M | 0.01% | Add | |
| 524.44K | $9.52M | 1.45% | Reduce | |
| 507.55K | $9.22M | 0.01% | Add | |
| 483.00K | $8.77M | 0.58% | Hold | |
| 483.00K | $8.77M | 0.29% | Hold | |
| 477.82K | $8.68M | 0.01% | Add | |
| 475.62K | $8.64M | 0.01% | New | |
| 441.98K | $8.03M | 0.30% | New | |
| 439.31K | $7.98M | 0.03% | Reduce | |
| 419.49K | $7.62M | 0.01% | Add | |
| 311.97K | $5.67M | 1.21% | Add | |
| 289.57K | $5.26M | 0.00% | Add | |
| 275.00K | $4.99M | 1.09% | Add | |
| 264.91K | $4.81M | 0.00% | Add |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.36M | $17.23M | 0.70% | Add | |
| 1.35M | $17.15M | 0.44% | Add | |
| 1.24M | $15.70M | 0.61% | Add | |
| 1.05M | $13.40M | 0.05% | New | |
| 1.01M | $12.79M | 1.23% | Add | |
| 833.33K | $10.59M | 1.48% | New | |
| 817.44K | $10.39M | 0.04% | New | |
| 720.92K | $9.16M | 1.30% | New | |
| 692.64K | $8.80M | 0.00% | Add | |
| 662.97K | $8.43M | 0.10% | Reduce | |
| 605.84K | $7.70M | 0.00% | Add | |
| 483.00K | $6.14M | 0.30% | Hold | |
| 483.00K | $6.14M | 0.30% | Hold | |
| 263.64K | $3.35M | 3.15% | Add | |
| 258.77K | $3.29M | 0.01% | New | |
| 228.30K | $2.90M | 0.07% | Add | |
| 213.57K | $2.71M | 0.00% | New | |
| 188.08K | $2.39M | 2.35% | New | |
| 178.10K | $2.26M | 1.65% | New | |
| 159.78K | $2.03M | 0.33% | Add | |
| 154.25K | $1.96M | 0.00% | Reduce | |
| 144.60K | $1.84M | 0.05% | Reduce | |
| 139.67K | $1.78M | 0.05% | Hold | |
| 137.43K | $1.75M | 0.00% | New | |
| 137.43K | $1.75M | 0.00% | New |
Q2 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 1.03M | $5.13M | 0.18% | Reduce | |
| 995.00K | $4.97M | 0.22% | Add | |
| 967.00K | $4.83M | 0.13% | Hold | |
| 932.97K | $4.66M | 0.08% | Reduce | |
| 607.87K | $3.03M | 0.47% | Reduce | |
| 567.10K | $2.83M | 0.09% | Reduce | |
| 483.00K | $2.41M | 0.17% | Hold | |
| 483.00K | $2.41M | 0.28% | Hold | |
| 406.57K | $2.03M | 0.00% | Add | |
| 261.02K | $1.30M | 0.02% | Reduce | |
| 166.94K | $833.04K | 0.00% | Hold | |
| 155.90K | $777.94K | 0.00% | Add | |
| 154.97K | $773.31K | 0.76% | Add | |
| 139.67K | $696.94K | 0.03% | Reduce | |
| 110.46K | $551.61K | 0.00% | Add | |
| 104.73K | $522.60K | 0.09% | Add | |
| 83.72K | $417.78K | 0.00% | Reduce | |
| 72.17K | $360.14K | 0.14% | Add | |
| 35.30K | $176.15K | 0.06% | Reduce | |
| 22.67K | $113.14K | 0.00% | Hold | |
| 20.61K | $102.86K | 0.00% | Add | |
| 12.89K | $64.32K | 0.00% | New | |
| 11.32K | $56.49K | 0.00% | New | |
| 10.98K | $54.77K | 0.00% | New | |
| 4.00K | $19.00K | 0.00% | New |
New Positions (Q2 2026)
- Deep Track Capital, LP 3.61M sh · $66.71M
- BRAIDWELL LP 1.63M sh · $30.11M
- PRICE T ROWE ASSOCIATES INC /MD/ 1.31M sh · $24.24M
- ALLIANCEBERNSTEIN L.P. 1.26M sh · $23.30M
- GEODE CAPITAL MANAGEMENT, LLC 1.11M sh · $20.43M
- Trails Edge Capital Partners, LP 891.88K sh · $16.48M
- Vestal Point Capital, LP 775.00K sh · $14.32M
- Parkman Healthcare Partners LLC 766.29K sh · $14.16M
- BAKER BROS. ADVISORS LP 550.00K sh · $10.16M
- SILVERARC CAPITAL MANAGEMENT, LLC 500.40K sh · $9.25M
- Davern Capital Partners, LP 468.67K sh · $8.66M
- Franklin Resources 404.19K sh · $7.47M
Fully Exited (vs previous quarter)
- T. Rowe Price Investment Management, Inc. sold 2.16M sh · $32.29M
- Millennium Management sold 835.48K sh · $12.47M
- MILLENNIUM MANAGEMENT LLC sold 835.48K sh · $12.47M
- ORBIMED ADVISORS LLC sold 475.17K sh · $7.09M
- JENNISON ASSOCIATES LLC sold 470.77K sh · $7.03M
- KENNEDY CAPITAL MANAGEMENT LLC sold 387.98K sh · $5.79M
- DV Trading LLC sold 360.06K sh · $5.38M
- Qube Research & Technologies Ltd sold 174.51K sh · $2.61M
- Hudson Bay Capital Management LP sold 161.09K sh · $2.41M
- Exome Asset Management LLC sold 159.34K sh · $2.38M
- STEMPOINT CAPITAL LP sold 134.74K sh · $2.01M
- Marshall Wace sold 129.14K sh · $1.93M
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fidelity Management & Research (FMR) | 5.25M | 5.10M | 2.88M | 220.30K | — | — | — | — | 1 | 2 | — | — | — | — | — | 13 | 35 | 1.22K | 249 | — |
| BlackRock Inc | 4.96M | 4.37M | 327.08K | 289.57K | 154.25K | 155.90K | 133.73K | 133.24K | 329 | — | — | — | — | — | — | — | — | — | — | — |
| Affinity Asset Advisors, LLC | 3.24M | 2.90M | 1.34M | 1.05M | 1.01M | 607.87K | 657.15K | 550.76K | 45.00K | 45.00K | 10.00K | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 2.56M | — | 71.65K | 79.25K | 45.45K | — | — | — | — | — | — | — | 25.64K | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.26M | 2.26M | 719.69K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Nantahala Capital Management, LLC | 2.14M | 1.86M | 1.24M | 1.24M | 1.24M | 995.00K | 900.00K | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Geode Capital Management | 1.26M | 1.11M | 169.89K | 166.15K | 104.19K | 110.46K | 107.81K | 104.85K | 10.11K | — | — | — | 133.52K | 80.97K | 51.33K | 51.33K | 51.42K | 846.39K | 1.36M | 1.33M |
| UBS Group AG | 770.06K | 1.21M | 1.14M | 477.82K | 45.21K | 83.72K | 98.95K | 98.52K | 6.13K | 3.58K | 7.71K | 2 | 112 | 1.92K | 2.35K | 6.18K | 6.76K | 8.53K | 22.39K | 17.79K |
| Davern Capital Partners, LP | 564.44K | 468.67K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Pivotal bioVenture Partners Investment Advisor LLC | 434.03K | 434.03K | 295.93K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 432.67K | 284.70K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| HRT FINANCIAL LP | 410.51K | — | 48.10K | — | — | — | 10.29K | 40.00K | — | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD FIDUCIARY TRUST CO | 333.32K | 324.81K | 86.43K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Fisher Asset Management, LLC | 316.50K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Vivo Capital, LLC | 275.00K | 275.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Eagle Health Investments LP | 235.09K | 235.09K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Aberdeen Group plc | 223.91K | 122.17K | 171.68K | 95.43K | 72.80K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| BNP PARIBAS FINANCIAL MARKETS | 221.29K | 134.09K | 422.78K | 197.75K | 5 | 5 | 4 | 4 | 4 | 4 | 4 | — | — | — | — | — | — | — | — | — |
| Verition Fund Management LLC | 210.33K | 38.24K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| NAN FUNG TRINITY (HK) Ltd | 189.00K | 189.00K | 189.00K | 189.00K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold AVTX?
As of 2026-Q2, 136 institutional funds reported holding AVTX (AVALO THERAPEUTICS INC) in SEC 13F filings, with a combined reported value of $1.32B.
How many shares of AVTX do institutions own?
13F filers reported 72.93M shares of AVTX, worth $1.32B in aggregate at the end of 2026-Q2.
Is institutional ownership of AVTX rising or falling?
Share counts moved +112.9% versus the prior quarter — accumulation.
Who are the top institutional holders of AVTX?
The largest 13F holders are Fidelity Management & Research (FMR), BlackRock Inc, Deep Track Capital, LP, Caligan Partners LP, TCG Crossover Management, LLC; the top 25 are ranked at the top of this page.
Who are the major shareholders of AVALO THERAPEUTICS INC?
The major shareholders of AVALO THERAPEUTICS INC (AVTX) by reported 13F value are Fidelity Management & Research (FMR), BlackRock Inc, Deep Track Capital, LP, Caligan Partners LP, TCG Crossover Management, LLC, among 224 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.